563P First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study

Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Kessler T, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Schmidt H, Lenz G. Mesters R, Berdel WE (2020)

In: (eds.), . (kein Verlag angegeben).

Research article in edited proceedings (conference)

Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma

Eisfeld, C, Eßeling, E, Wullenkord, R, Khandanpour, C, Reusch, J, Mikesch, JH, Reicherts C, Kerkhoff A, Schliemann C, Kessler T, Mesters RM, Berdel WE, Lenz G, Stelljes M (2020)

In: Annals of Hematology, 99(8).

Research article (journal)

Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: Two parallel patient cohorts treated in a single center

Pohlen Michele , Marx Julia , Mellmann Alexander , Becker Karsten ,Mesters Rolf M , Mikesch Jan-Henrik, Schliemann Christoph , Lenz Georg , Müller-Tidow Carsten , Büchner Thomas , Krug Utz , Stelljes Matthias , Karch Helge , Peters Georg , Gerth Ulrich , Görlich Dennis , Berdel Wolfgang E (2016)

In: Haematologica, 101(10).

Research article (journal)

Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT

Sauer T, Silling G, Groth C, Rosenow F, Krug U, Gorlich D, Evers G, Albring J, Besoke R, Mesters RM, Muller-Tidow C, Kessler T, Buchner T, Berdel WE, Stelljes M (2015)

In: Bone Marrow Transplantation, 50(4).

Research article (journal)

Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients.

Liersch R, Gerss J, Schliemann C, Bayer M, Schwöppe C, Biermann C, Appelmann I, Kessler T, Löwenberg B, Büchner T, Hiddemann W, Müller-Tidow C, Berdel WE, Mesters R (2012)

In: Blood, 119(22).

Research article (journal)

Publications

Contact

Top-Links

Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma Brand V, Greve B, Bölling T, Eich HT, Willich N, Harrach S, Hintelmann H, Lenz G, Mesters RM, Kessler T, Schliemann C, Berdel WE, Schwöppe C (2020) In: PloS one, 15(2). Research article (journal)
563P First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Kessler T, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Schmidt H, Lenz G. Mesters R, Berdel WE (2020) In: (eds.), . (kein Verlag angegeben). Research article in edited proceedings (conference)
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study Schliemann C, Gerwing M, Heinzow H, Harrach S, Schwöppe C, Wildgruber M, Hansmeier AA, Angenendt L, Berdel AF, Stalmann U, Berning B, Kratz-Albers K, Middelberg-Bisping K, Wiebe S, Albring J, Wilms C, Hartmann W, Wardelmann E, Krähling T, Heindel W, Gerss J, Bormann E, Schmidt H, Lenz G, Kessler T, Mesters RM, Berdel WE (2020) In: Cancers, 12(6). Research article (journal)
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma Eisfeld, C, Eßeling, E, Wullenkord, R, Khandanpour, C, Reusch, J, Mikesch, JH, Reicherts C, Kerkhoff A, Schliemann C, Kessler T, Mesters RM, Berdel WE, Lenz G, Stelljes M (2020) In: Annals of Hematology, 99(8). Research article (journal)
Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (>= 60 years) Pohlen M, Groth C, Sauer T, Görlich D, Mesters R, Schliemann C, Lenz G, Müller-Tidow C, Büchner T, Berdel WE, Stelljes M (2016) In: Bone Marrow Transplantation, 51. Research article (journal)
Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: Two parallel patient cohorts treated in a single center Pohlen Michele , Marx Julia , Mellmann Alexander , Becker Karsten ,Mesters Rolf M , Mikesch Jan-Henrik, Schliemann Christoph , Lenz Georg , Müller-Tidow Carsten , Büchner Thomas , Krug Utz , Stelljes Matthias , Karch Helge , Peters Georg , Gerth Ulrich , Görlich Dennis , Berdel Wolfgang E (2016) In: Haematologica, 101(10). Research article (journal)
Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia Büchner T., Krug U., Peter Gale R., Heinecke A., Sauerland M., Haferlach C., Schnittger S., Haferlach T., Müller-Tidow C., Stelljes M., Mesters R., Serve H., Braess J., Spiekermann K., Staib P., Grüneisen A., Reichle A., Balleisen L., Eimermacher H., Giagounidis A., Rasche H., Lengfelder E., Görlich D., Faldum A., Köpcke W., Hehlmann R., Wörmann B., Berdel W., Hiddemann W. (2016) In: Leukemia, 30. Research article (journal)
Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT Sauer T, Silling G, Groth C, Rosenow F, Krug U, Gorlich D, Evers G, Albring J, Besoke R, Mesters RM, Muller-Tidow C, Kessler T, Buchner T, Berdel WE, Stelljes M (2015) In: Bone Marrow Transplantation, 50(4). Research article (journal)
Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor. Liersch R, Shin JW, Bayer M, Schwöppe C, Schliemann C, Berdel WE, Mesters R, Detmar M (2012) In: International Journal of Oncology, 2012. Research article (journal)
Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients. Liersch R, Gerss J, Schliemann C, Bayer M, Schwöppe C, Biermann C, Appelmann I, Kessler T, Löwenberg B, Büchner T, Hiddemann W, Müller-Tidow C, Berdel WE, Mesters R (2012) In: Blood, 119(22). Research article (journal)